Live Breaking News & Updates on Cognitive Difficulties

Stay updated with breaking news from Cognitive difficulties. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mental health problems come with an added 'cost' of poorer cognitive function – a neuropsychologist explains

While only about 20% of people would qualify for a formal diagnosis of a mental disorder, more than 60% express symptoms of those disorders – and those symptoms can lead to cognitive difficulties. ....

United States , Research Brief , Clinical Psychology , Statistical Manual , Cognitive Dysfunction , Mental Health Disorders , Ognitive Function , Cognitive Difficulties , Cognitive Tests , Mental Health , Cognitive Functioning , Cognitive Abilities , Executive Functions ,

Exploring the Impact of COVID-19 on the Brain and Body

COVID-19 patients who reported cognitive difficulties were more likely to experience long-term physical symptoms. ....

Covid 19 , Cognitive Difficulties , Memory Loss , Physical Symptoms , Long Term Effects , Ovid 19 Recovery ,

One in 10 older adults in U.S. has dementia: research-Xinhua

One in 10 older adults in U.S. has dementia: research- ....

United States , Washington Post , African American , Cognitive Difficulties ,

Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International. ....

New York , United States , Alex Braun , Craig Hopkinson , Marisa Borgasano , Aripiprazole Lauroxil , Behavioral Health System , Research Databases , Schizophrenia International Research Society , Research Development At Alkermes , Department Of Psychiatry , Icahn School Of Medicine At Mount Sinai , Alkermes Inc , Alkermes Pharma Ireland , Detailed Results Presented From , Early Phase , Patients Early , New York Assessment , Adverse Cognitive Effects , Neuropsychiatric Treatment , Chief Medical Officer , Executive Vice President , Young Adults , Schizophreniform Disorder , Bipolari Disorder Who Are Early , Their Illness ,

Alkermes plc: Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

- Detailed Results Presented From ENLIGHTEN-Early Phase 3b Study of LYBALVI in Patients Early in Illness - DUBLIN, April 7, 2022 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today presented ....

New York , United States , Alex Braun , Craig Hopkinson , Marisa Borgasano , Aripiprazole Lauroxil , Behavioral Health System , Research Databases , Schizophrenia International Research Society , Research Development At Alkermes , Department Of Psychiatry , Icahn School Of Medicine At Mount Sinai , Alkermes Inc , Alkermes Pharma Ireland , Results Presented From , Early Phase , Patients Early , New York Assessment , Adverse Cognitive Effects , Neuropsychiatric Treatment , Chief Medical Officer , Executive Vice President , Young Adults , Schizophreniform Disorder , Bipolari Disorder Who Are Early , Their Illness ,